# High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/high-dose-intravenous-immunoglobulin-as-a-therapeutic-option-for-deteriorating/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wei Cao,Xiaosheng Liu,Tao Bai,Hongwei Fan,Ke Hong,Hui Song,Yang Han,Ling Lin,Lianguo Ruan,Taisheng Li |
| Citations | 419 |
| DOI | 10.1093/ofid/ofaa102 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://academic.oup.com/ofid/article-pdf/7/3/ofaa102/32987821/ofaa102.pdf |
| OpenAlex ID | https://openalex.org/W3011183720 |
| PMID | 32258207 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Tao Bai](https://scholariq.org/researchers/tao-bai/)

## Paper journal

- [Open Forum Infectious Diseases](https://scholariq.org/journals/open-forum-infectious-diseases/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.